Join to View Full Profile
Medical Oncology and Therapeutics Research1500 East Duarte RoadDuarte, CA 91010
Phone+1 626-256-4673
Fax+1 626-218-8233
Dr. Xing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Methodist Hospital (Houston)Fellowship, Hematology and Medical Oncology, 2015 - 2017
Mount Auburn HospitalResidency, Internal Medicine, 2012 - 2015
Sun Yat-Sen University of Medical ScienceClass of 1994
Certifications & Licensure
CA State Medical License 2018 - 2026
TX State Medical License 2017 - 2025
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers Start of enrollment: 2019 Apr 15
Publications & Presentations
PubMed
- The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective Study.Ramya Muddasani, Helena T Wu, Shwe Win, Arya Amini, Badri Modi
Cancers. 2024-12-28 - 2 citationsAdvancements and Challenges in Personalized Therapy for-Mutant Melanoma: A Comprehensive Review.Abdulaziz Shebrain, Omer A Idris, Ali Jawad, Tiantian Zhang, Yan Xing
Journal of Clinical Medicine. 2024-09-12 - 1 citationsA phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, Drew Rasco, Yan Xing
Investigational New Drugs. 2024-06-01
Press Mentions
Defence to Perform Final AccuTOXTM Preclinical Study Before Phase I Cancer TrialMarch 29th, 2023- Defence to Complete a Final Pre-Clinical Study Prior to Ind Filings for the Accutoxtm Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research InstituteMarch 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
